← Leaderboards
Shelly L Gray
University Of Washington
$5,959,165
Attributed
$7,402,326
Total exposure
4
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.4M · FY2018–25$2M$1.5M$1M$500K$0
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$4,516,004 · 3
CDC$2,886,322 · 1
By mechanism
U19$4,216,457 · 2
U01$2,886,322 · 1
K08$299,547 · 1
Top collaborators
- Elizabeth Anne Phelan4 shared
Most similar at University Of Washington
Same institution · by research overlap
- Bruce M Psaty$64,428,295
- Jashvant D Unadkat$14,909,800
- Kenneth M. Rice$14,829,400
- Eric B Larson$50,741,279
- Ronald Y Kwon$3,595,926
Others in their field
Top investigators on “Epidemiology”
- David Heimbrook · Leidos Biomedical Research, Inc.$390,770,069
- George R Seage · Abt Associates, Inc.$299,251,523
- Jeffrey P Krischer · University Of South Florida$264,076,260
- Barbara Driver · Westat, Inc.$221,167,491
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$206,739,528
- James Dennis Neaton · Northwestern University$203,539,316
Research focus
EpidemiologyComparativeAngiotensin ReceptorAdultAdrenergic Beta-AntagonistsCohort StudiesAlzheimer&AposCell LineAnti-CholinergicsAmyloid Beta-ProteinAngiotensin-Converting Enzyme InhibitorsAntihistaminesAngiotensin IiCellsChronicBenefits And RisksAngiotensinsBiologicalBloodBlood PressureBrainBrain HealthBrain VolumeCohort
Grant awards (12)
Translational pharmacoepidemiology: neuroprotection and neurotoxicity of antihypertensives and strong anticholinergics$1,292,161
U19 · FY2025 · AG · contact PI
Translational pharmacoepidemiology: neuroprotection and neurotoxicity of antihypertensives and strong anticholinergics$983,554
U19 · FY2024 · AG · contact PI
Translational pharmacoepidemiology: neuroprotection and neurotoxicity of antihypertensives and strong anticholinergics$638,623
U19 · FY2023 · AG · contact PI
Translational pharmacoepidemiology: neuroprotection and neurotoxicity of antihypertensives and strong anticholinergics$632,235
U19 · FY2022 · AG · contact PI
Reducing CNS-active Medications to Prevent Falls and Injuries in Older Adults$707,624
U01 · FY2021 · CE
Translational pharmacoepidemiology: neuroprotection and neurotoxicity of antihypertensives and strong anticholinergics$669,884
U19 · FY2021 · AG · contact PI
Reducing CNS-active Medications to Prevent Falls and Injuries in Older Adults$679,253
U01 · FY2020 · CE
Reducing CNS-active Medications to Prevent Falls and Injuries in Older Adults$749,506
U01 · FY2019 · CE
Reducing CNS-active Medications to Prevent Falls and Injuries in Older Adults$749,939
U01 · FY2018 · CE
BENZODIAZEPINE USE AND RISK OF DISABILITY IN THE ELDERLY$100,831
K08 · FY2003 · AG
BENZODIAZEPINE USE AND RISK OF DISABILITY IN THE ELDERLY$100,563
K08 · FY2002 · AG
BENZODIAZEPINE USE AND RISK OF DISABILITY IN THE ELDERLY$98,153
K08 · FY2001 · AG